Free Trial

Assembly Biosciences (ASMB) Stock Forecast & Price Target

+0.16 (+1.06%)
(As of 07/23/2024 ET)

Assembly Biosciences - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 1 Wall Street analysts who have issued ratings for Assembly Biosciences in the last 12 months, the stock has a consensus rating of "Hold." Out of the 1 analysts, 1 has given a hold rating for ASMB.

Consensus Price Target


According to the 1 analysts' twelve-month price targets for Assembly Biosciences,

TypeCurrent Forecast
7/24/23 to 7/23/24
1 Month Ago
6/24/23 to 6/23/24
3 Months Ago
4/25/23 to 4/24/24
1 Year Ago
7/24/22 to 7/24/23
Consensus Rating
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
1 Buy rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/A$26.00
Forecasted UpsideN/AN/AN/A61.29% Upside
Get Assembly Biosciences Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ASMB and its competitors with MarketBeat's FREE daily newsletter.

ASMB Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ASMB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Assembly Biosciences Stock vs. The Competition

TypeAssembly BiosciencesMedical CompaniesS&P 500
Consensus Rating Score
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside3,059.07% Upside9.72% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/20/2024HC Wainwright
3 of 5 stars
 Reiterated RatingNeutral
2 of 5 stars
 Lower TargetBuy$168.00 ➝ $36.00+115.83%
10/24/2022Truist Financial
1 of 5 stars
 DowngradeBuy ➝ Hold$132.00 ➝ $24.00+27.39%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 11:54 PM ET.

ASMB Forecast - Frequently Asked Questions

Should I buy or sell Assembly Biosciences stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Assembly Biosciences in the last twelve months. There is currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" ASMB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ASMB, but not buy additional shares or sell existing shares.

What analysts cover Assembly Biosciences?

Assembly Biosciences has been rated by research analysts at HC Wainwright in the past 90 days.

Do Wall Street analysts like Assembly Biosciences more than its competitors?

Analysts like Assembly Biosciences less than other "medical" companies. The consensus rating for Assembly Biosciences is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ASMB compares to other companies.

This page (NASDAQ:ASMB) was last updated on 7/23/2024 by Staff

From Our Partners